CD274 and neoplasm: It is reported that depletion of CD274+ tumour‐associated neutrophils is a promising immunotherapy target to inhibit tumor progression.[55] Immunotherapies reversing the immunosuppressive phenotype of neutrophils may be beneficial to the treatment of AE patients.